JBJS, May 1, 2001, Volume 83, Issue 5

Erythropoietin Reduced the Need for Allogeneic Blood Transfusion in Total Hip Joint Arthroplasty

B G Feagan C J Wong A Kirkley D W Johnston F C Smith P Whitsitt S L Wheeler C Y Lau

Hip

Question: In patients having total hip joint arthroplasty, does erythropoietin (epoetin alfa) (Eprex; Janssen-Ortho Inc., Toronto, Ontario, Canada) reduce the need for allogeneic blood transfusions?

Link to article